4DMedical is trading at A$2.39, up 11.16%, with no confirmed company-specific announcement identified to explain the rise. - The company’s recent ASX response said it knew of no undisclosed information and cited increased short interest as a possible explanation for earlier volatility. - A substantial-holder notice is listed for November 5, but available information does not establish it as the cause of this move. - The supplied sector context is not enough to confirm a direct link.